key: cord-0897063-mln4yb2n authors: Park, Jin Hong; Kummerlowe, Megan; Gardea Resendez, Manuel; Nuñez, Nicolas A.; Almorsy, Ammar; Frye, Mark A. title: First manic episode following COVID‐19 infection date: 2021-09-19 journal: Bipolar Disord DOI: 10.1111/bdi.13123 sha: f0049351f54d408582103a50c6ca0507a1ab1920 doc_id: 897063 cord_uid: mln4yb2n A 56-year-old Caucasian male with no past psychiatric history presented to the Emergency Department (ED) for evaluation of new onset (24 hours) odd and erratic behavior preceded by a 4-week period of decreased need for sleep, averaging two hours per night. The sleep pattern change began within one week of an untreated symptomatic upper respiratory infection suspected to be due to COVID-19. On presentation to the ED, he endorsed fluctuating mood, increased energy, distractibility, and overvalued religious ideation that he was a prophet, although this was not a fixed belief. He was conceptually disorganized, responded to religiously themed command auditory hallucinations, but demonstrated fair insight into his unusual behavior. Family and personal past psychiatric history both were unremarkable. Medical workup in the ED included head computerized tomography (CT), general laboratory studies, and SARS-Coronavirus-2 RNS testing; other than mild neutrophilia and thrombocytosis, all studies were negative. He was admitted to the medical service for further evaluation. Risperidone 1 mg daily for psychotic symptoms and lorazepam 1 mg at bedtime for sleep were initiated. A 56-year-old Caucasian male with no past psychiatric history presented to the emergency department (ED) for evaluation of new onset (24 h) odd and erratic behavior preceded by a 4-week period of decreased need for sleep, averaging 2 h per night. The sleep pattern change began within 1 week of an untreated symptomatic upper respiratory infection suspected to be due to COVID-19. On presentation to the ED, he endorsed fluctuating mood, increased energy, distractibility, and overvalued religious ideation that he was a prophet, although this was not a fixed belief. He was conceptually disorganized, responded to religiously themed command auditory hallucinations, but demonstrated fair insight into his unusual behavior. Family and personal past psychiatric history both were unremarkable. Medical workup in the ED included head computed tomography, general laboratory studies, and SARS-Coronavirus-2 RNS testing; other than mild neutrophilia and thrombocytosis, all studies were negative. He was admitted to the medical service for further evaluation. Risperidone 1 mg daily for psychotic symptoms and lorazepam 1 mg at bedtime for sleep were initiated. Additional inpatient medical workup included brain magnetic resonance imaging, which was negative for any enhancing lesions or signs of encephalitis. Screening for autoimmune disorders, heavy metals, drug use, HIV, and sexually transmitted disease testing was negative. SARS-CoV-2 nucleocapsid total antibody was positive. This antibody, with an elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) with neutrophilia and thrombocytosis, was suggestive of an acute inflammatory state and recent COVID-19 infection. He did not receive COVID-19 vaccination. His symptoms rapidly improved following 24 h of hospitalization. Given such rapid response, a diagnosis of brief psychotic disorder was made, and he was discharged home with no follow-up medications. Ten days post hospital discharge, he re-presented to the ED with labile mood, increased energy, pressured speech, talkativeness, distractibility, overvalued religious thought, and brain fog. This was a classic manic episode of elevated mood and energy. Given his previous positive response to medications, risperidone 1 mg was re-started with scheduled outpatient follow-up. One week later, at outpatient psychiatric follow-up, risperidone was further increased to 2 mg due to continuation of hyperactivity though his sleep had improved to 7 h per night. To our knowledge, this is the first observation of a manic episode with psychosis following a suspected mild symptomatic COVID-19 infection in a patient not treated with corticosteroids or antibiotics. Given the negative past psychiatric history and the relatively uncommon first episode age of onset, we hypothesize this manic episode is related to prior COVID-19 infection. This is further supported by the elevation in ESR and CRP in an otherwise healthy patient and appears consistent with a COVID-19-associated manic episode. Unlike the typical characteristics of older age bipolar disorder, defined as individuals over 50 years old, this case has no risk factors for cerebrovascular disease or structural brain abnormalities including stroke, tumor, or white matter hyperintensities. This patient was initially diagnosed with brief psychotic disorder based on the predominant psychotic presentation in the ED. There is one case report of manic-like symptoms in the setting of COVID-19 infection in China. 1 As in our case, they also report new manic-like symptoms in a patient with no previous psychiatric history. There was rapid reduction in manic symptoms after initiation of antipsychotic treatment; as the authors noted, the patient had received high-dose methylprednisolone for treatment of symptomatic COVID-19 infection, which is known to precipitate mood episodes. 2 There are also two case reports of psychotic depression The hypothesis has been suggested that viral infections are related to the pathogenesis of bipolar disorder. COVID-19 infection could trigger an initial manic episode, which rapidly improves following treatment with atypical antipsychotics. Prolonged treatment needs to be considered even after the early remission as with typical manic episodes. Maintenance treatment for mood stabilization should be considered and further investigated if there are differential pharmacological outcomes compared with typical manic episodes. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic Letter to the Editor: new onset psychosis and mania following COVID-19 infection Association of cytomegalovirus and toxoplasma gondii antibody titers with bipolar disorder Can bipolar disorder be viewed as a multi-system inflammatory disease?